5/21
07:13 am
clsd
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® [Yahoo! Finance]
High
Report
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA® [Yahoo! Finance]
5/21
07:05 am
clsd
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
High
Report
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
5/13
08:09 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
5/13
08:09 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its price target lowered by analysts at HC Wainwright from $6.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its price target lowered by analysts at HC Wainwright from $6.00 to $5.00. They now have a "buy" rating on the stock.
5/11
12:15 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
5/10
12:10 pm
clsd
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/9
04:24 pm
clsd
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
5/9
04:05 pm
clsd
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
5/8
04:15 pm
clsd
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
Medium
Report
Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
4/30
07:10 am
clsd
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 [Yahoo! Finance]
Medium
Report
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 [Yahoo! Finance]
4/30
07:05 am
clsd
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024
Medium
Report
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024
4/16
07:10 am
clsd
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors [Yahoo! Finance]
Medium
Report
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors [Yahoo! Finance]
4/16
07:05 am
clsd
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
Medium
Report
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
4/11
08:06 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $4.00 price target on the stock.
4/2
07:07 am
clsd
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
High
Report
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
4/2
07:05 am
clsd
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
High
Report
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
3/18
03:10 pm
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/18
07:09 am
clsd
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer [Yahoo! Finance]
3/18
07:05 am
clsd
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
Medium
Report
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
3/13
10:20 am
clsd
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $5.00.
Medium
Report
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $5.00.
3/13
08:54 am
clsd
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/12
04:15 pm
clsd
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/12
04:05 pm
clsd
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Medium
Report
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
3/6
02:36 pm
clsd
These 2 ‘Strong Buy' Penny Stocks Could Surge Over 200%, Say Analysts [Yahoo! Finance]
Medium
Report
These 2 ‘Strong Buy' Penny Stocks Could Surge Over 200%, Say Analysts [Yahoo! Finance]